S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
LON:MCGN

Microgen (MCGN) Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
367.50
367.50
52-Week Range
N/A
Volume
26,257 shs
Average Volume
15,829 shs
Market Capitalization
£224.83 million
P/E Ratio
17.09
Dividend Yield
1.65%
Beta
N/A

Receive MCGN News and Ratings via Email

Sign-up to receive the latest news and ratings for Microgen and its competitors with MarketBeat's FREE daily newsletter.

Microgen logo

About Microgen

Microgen plc, together with its subsidiaries, develops, implements, and supports business critical software and related services in the United Kingdom and internationally. It operates through two segments, Aptitude Software and Microgen Financial Systems. The Aptitude Software segment provides a suite of specialized finance management software applications for banking, healthcare, insurance, and telecommunications customers. Its applications include Aptitude Insurance Calculation Engine that focuses on insurance contracts; Aptitude Lease Accounting Engine, which addresses leasing standards; Aptitude Revenue Recognition Engine for revenue recognition requirements; Aptitude RevStream, a cloud-enabled revenue management software; Aptitude Accounting Hub that transforms financial, management, and statutory accounting; and Aptitude Allocation Engine that offers interfaces to set-up and apply rules to allocate cost and revenue. This segment licenses its software; and provides software maintenance/support, software subscriptions for its cloud-based offerings; and implementation services. The Microgen Financial Systems segment offers Microgen 5Series, a wealth management software for both on-shore and off-shore markets; and Microgen Bacway, a suite of payments software products. It also provides maintenance, support, and development services on a range of software products and applications developed by third parties. Microgen plc was founded in 1974 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Technical & System Software
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
£70.29 million
Book Value
GBX 106 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£224.83 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.28 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Microgen (LON:MCGN) Frequently Asked Questions

Is Microgen a good dividend stock?

Microgen pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 1.65%. The dividend payout ratio of Microgen is 0.33%. This payout ratio is at a healthy, sustainable level, below 75%.
View Microgen's dividend history.

Who are Microgen's key executives?
Microgen's management team includes the following people:
  • Mr. Philip B. Wood, CFO, Group Fin. Director, Exec. Director & Member of the Operating Board (Age 46)
  • Mr. Tom Crawford, CEO of Aptitude Software & Exec. Director (Age 51)
  • Mark Heather, Company Sec.
  • Martin Redington, Chief Technology Officer of Aptitude Software
What other stocks do shareholders of Microgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microgen investors own include Quantum Materials (QTMM), 6014185 (TIG.L) (TIG), Telecom Plus (TEP), Sophos Group plc (SOPH.L) (SOPH), Photo-Me International (PHTM), Interserve (IRV), Harvey Nash Group (HVN) and BAE Systems (BA).

What is Microgen's stock symbol?

Microgen trades on the London Stock Exchange (LON) under the ticker symbol "MCGN."

How do I buy shares of Microgen?

Shares of MCGN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does Microgen make?

Microgen has a market capitalization of £0.00 and generates £70.29 million in revenue each year.

What is Microgen's official website?

The official website for Microgen is www.microgen.com.

How can I contact Microgen?

Microgen's mailing address is Old Change House 128 Queen Victoria Street, LONDON, EC4V 4BJ, United Kingdom. The company can be reached via phone at +44-20-74968100.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.